Singapore Health Sciences Authority (HSA) approval marks the first in a series of expected approvals of trodelvy in Asia
Newly formed Life Science Services business unit to offer fully integrated CDMO and Contract Testing Services
Sun Pharma’s Q3FY22 operational performance was in line with I-direct estimates with sustained momentum and good growth across businesses
ICICI Direct’s analysis of Cipla’s Q3FY22 results
The agreement is for the development and commercialisation of JHU’s novel target and technology that will help patients with colorectal cancer
Company to manufacture drug substance for clinical supply of HaemaLogiX’s lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facility in Guangzhou, China
Cipla announced its unaudited consolidated financial results for quarter ended December 31st, 2021.
Philips expands remote cardiac monitoring portfolio with patch-based, clinical-grade ECG designed to improve patient recruitment, compliance and retention by reducing need for site visits during clinical trials
Optimized for pharma/biopharma to deliver a deeper understanding of cellular function
Studies show significant reduction in pain and improved quality of life for patients treated with spinal cord stimulation compared to medication management alone
Subscribe To Our Newsletter & Stay Updated
